Saturna Capital’s Mesa Laboratories MLAB Stock Holding History

Saturna Capital’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,800	Closed	-$367K	–	164
2022 Q2	$367K	Hold	1,800	–	–	0.01%	136
2022 Q1	$459K	Hold	1,800	–	–	0.01%	130
2021 Q4	$591K	Hold	1,800	–	–	0.01%	123
2021 Q3	$544K	Hold	1,800	–	–	0.01%	127
2021 Q2	$488K	Buy	1,800 +900	+100%	+$228K	0.01%	133
2021 Q1	$219K	Hold	900	–	–	﹤0.01%	158
2020 Q4	$258K	Hold	900	–	–	0.01%	157
2020 Q3	$229K	Sell	900 -1,000	-53%	-$238K	0.01%	153
2020 Q2	$412K	Hold	1,900	–	–	0.01%	131
2020 Q1	$430K	Hold	1,900	–	–	0.01%	127
2019 Q4	$474K	Hold	1,900	–	–	0.01%	135
2019 Q3	$452K	Buy	1,900 +700	+58%	+$162K	0.01%	135
2019 Q2	$293K	Buy	+1,200	New	+$279K	0.01%	152

Other funds holding MLAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Saturna Capital's MLAB Position: Q3 2022 in Review

Saturna Capital sold out of Mesa Laboratories (MLAB) in Q3 2022, closing a stake of 1,800 shares — an estimated $367K sold.

Saturna Capital first reported a position in MLAB in Q2 2019 and held it in 13 quarters. The position peaked at $591K in Q4 2021. 163 funds tracked by Wall St. Rank hold MLAB as of Q3 2022.

Saturna Capital reported no remaining Mesa Laboratories position as of Q3 2022 after selling out during the quarter.
Saturna Capital sold 1,800 Mesa Laboratories shares in Q3 2022, an estimated $367K.
Saturna Capital first reported a position in Mesa Laboratories in Q2 2019 and held it in 13 quarters.
Saturna Capital's Mesa Laboratories position peaked at $591K in Q4 2021.
163 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2022.

Based on Saturna Capital's 13F filing for Q3 2022, filed 10 Nov 2022.